Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGD

Clinical trial NCT06638034 · RECRUITING

Trial details

NCT number: NCT06638034
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

FAP- Expressing Positive Tumors RGD- Expressing Positive Tumors

Start date: 2024-05-01
Primary completion: 2025-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.